Donate

News & Statements

T1International Names Nicole Smith-Holt Ambassador

T1International Names Nicole Smith-Holt Ambassador

T1International is proud and honoured to announce that Nicole Smith-Holt as accepted our invitation to serve as T1International Charity Ambassador. Read more

Pamoja Advocacy Training in Ghana

Pamoja Advocacy Training in Ghana

‘Pamoja’ is a Swahili word that means together. This was the underpinning spirit of the advocacy training. Pamoja advocates worked together on education-focused advocacy goals throughout the training. Goals are country-specific, but similar enough that sharing and support can happen between all the advocates from each of the five countries. Read more

My Experience as an Intern for T1International

My Experience as an Intern for T1International

In this instance I was glad to get to know all the advocacy that T1International carries out for and with people with type 1 diabetes. Working with T1International and seeing the good they can do through their social media accounts alone has proven to be really inspiring. It was great to see how one charity, through all its projects, can make such a step towards a better life for those with type 1 diabetes. Read more

Nicole Smith-Holt Statement on Eli Lilly Helpline Announcement

Nicole Smith-Holt Statement on Eli Lilly Helpline Announcement

I vow to continue to fight for the rights and lives of all people with diabetes. I am doing all this in honor of my son, Alec Raeshawn Smith. I invite Lilly to work with me and non-industry funded organizations like T1International so that we can find real solutions to ensure #insulin4all. Mr. Mason, I am still waiting to hear from you. Read more

T1International Statement on #insulin4all for Civil Society Hearing on NCDs

The high price of life-saving medications, including the rising prices of insulin, are killing people living with NCDs worldwide. Families are being financially ruined here in the United States, and around the world. This reality is not complicated to understand but it is impossible for us to live with. Read more

T1International Statement on Walmart Insulin

T1International Statement on Walmart Insulin

Recently, the American Diabetes Association issued a white paper on Insulin Access and Affordability by their Working Group. While we continue to applaud the American Diabetes Association for speaking out about the high cost of insulin, we remain concerned with their approach and some of the recommendations in their paper.
Read more

My Journey to Eli Lilly HQ for Answers

My Journey to Eli Lilly HQ for Answers

I was very nervous before going to confront the top executives of Eli Lilly and Company. But I was determined to tell them Alec’s story. They needed to hear from me what their insulin prices did to Alec, and are still doing to others. Read more

T1International Testimony for Insulin Access & Affordability: The Rising Cost of Treatment

T1International’s 2018 global survey explored out-of-pocket costs for people with type 1 diabetes. More than 25% of American respondents said that they have had to ration insulin at least once per year due to cost. Fourteen percent of those respondents have had to ration their insulin monthly, weekly, or daily due to insulin cost. Read more

Patient Activism is Seizing the Spotlight—And Rightly So

Patient Activism is Seizing the Spotlight—And Rightly So

In today’s struggle on insulin pricing and other drugs, patient can win the day again. So our organization, People of Faith for Access to Medicines, is proud to be in support of T1International’s amazing work, from the Eli Lilly demonstration to the #insulin4all meetups in New York City and the Cincinnati area. Read more

World Health Day: Universal Health Coverage (#healthforall)

World Health Day: Universal Health Coverage (#healthforall)

Excitingly, the WHO has chosen to highlight Universal Health Coverage in 2018 by choosing it as the theme for World Health Day on April 7th. At T1International, we will use the day to continue to highlight the importance of Universal Health Coverage for people with type 1 diabetes. Read more